Blog

The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.

BACK TO BLOG

Author: Noel Lloyd

Date: March 29th, 2016

On April 7, the Alliance's Vice President of Public Policy Cynthia Bens will participate in a symposium titled "Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target" at the 28th Annual EuroMeeting in Hamburg, Germany.

This session will look at the progress that has been made in drug development for and with older adults.  It "will announce and discuss the brand new EMA Geriatric Working Party frailty definition selected for study baseline characteristics for clinical studies and propose how this will change the research landscape in geriatric studies in Europe and beyond." 

During the session, Bens will address areas of need and insufficient research in the frailty arena. She joins the following experts: Susan Morgan, Medicines & Healthcare Products Regulatory Agency (MHRA), United Kingdom; Susanna Del Signore, M.D., Bluecompanion, United Kingdom; Antonio Cherubini, IRCCS-INRCA, Italy; and Francesca Cerreta, European Medicines Agency, European Union.

To find out more, go to the session information page. 

 

 






A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It